Pharmaceuticals Industry Financing Agreements

Third Amendment to Revenue Interest Financing Agreement, dated as of July 27, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Liquidia Corp, Filed With SEC on August 10, 2023)

Second Amendment to Revenue Interest Financing Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Liquidia Corp, Filed With SEC on August 10, 2023)

Revenue Interest Financing Agreement, dated October 28, 2022, by and between Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (MARINUS PHARMACEUTICALS INC, Filed With SEC on November 7, 2022)

Amendment No. 16 to Financing Agreement, dated July 29, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV... (TherapeuticsMD, Inc., Filed With SEC on August 1, 2022)

Amendment No. 10 to Financing Agreement, dated May 27, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV... (TherapeuticsMD, Inc., Filed With SEC on May 31, 2022)

Equity Financing Agreement (GREEN HYGIENICS HOLDINGS INC., Filed With SEC on September 17, 2020)

Equity Financing Agreement by and between Green Hygienics Holdings, Inc. and GHS Investments, LLC, dated September 13, 2020 (GREEN HYGIENICS HOLDINGS INC., Filed With SEC on September 14, 2020)

Equity Financing Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on August 13, 2020)

Revenue Interest Financing Agreement, dated April 7, 2020, by and between the Company and HealthCare Royalty Partners IV, L.P (CHIASMA, INC, Filed With SEC on May 7, 2020)

Amended Bridge Debt Financing Agreement dated June 1, 2019 (Accelerated Pharma, Inc., Filed With SEC on October 21, 2019)

Amended Bridge Debt Financing Agreement dated June 1, 2019 (Accelerated Pharma, Inc., Filed With SEC on July 24, 2019)

November 15, 2017 Amendment to May 2017 Financing Agreement (Kaya Holdings, Inc., Filed With SEC on November 20, 2017)

July 31, 2017 Amendment to May 11, 2017 Financing Agreement (Kaya Holdings, Inc., Filed With SEC on August 21, 2017)

$5.8 M Financing Agreement (Kaya Holdings, Inc., Filed With SEC on May 22, 2017)

Financing Agreement (Kaya Holdings, Inc., Filed With SEC on January 6, 2017)

Form of subscription agreement for the financing (Lexaria Bioscience Corp., Filed With SEC on September 6, 2016)

Form of subscription agreement for the financing (Lexaria Bioscience Corp., Filed With SEC on August 16, 2016)

Medbox Completes $4.5-Million Financing - Funds to be used for Corporate Purposes, Including Further Implementation of Strategic Growth Plan - (Notis Global, Inc., Filed With SEC on August 26, 2015)

AMENDED AND RESTATED STANDBY BRIDGE FINANCING AGREEMENT Dated as of December 3, 2014 By and Among GPB LIFE SCIENCE HOLDINGS LLC (CO-LENDER) 31 GROUP LLC (CO-LENDER) and JAGUAR... (Jaguar Health, Inc., Filed With SEC on April 17, 2015)

Lang Financing Agreement (TherapeuticsMD, Inc., Filed With SEC on February 2, 2012)

Lang Financing Agreement (TherapeuticsMD, Inc., Filed With SEC on December 9, 2011)

FINANCING AGREEMENT Dated as of June 30, 2011 between ZOGENIX, INC. and COWEN HEALTHCARE ROYALTY PARTNERS II, L.P. TABLE OF CONTENTS (ZOGENIX, INC., Filed With SEC on August 12, 2011)

OPTIMER BIOTECHNOLOGY, INC. FINANCING AGREEMENT (OPTIMER PHARMACEUTICALS INC, Filed With SEC on November 3, 2009)

the Companys ability to obtain necessary financing (VIA Pharmaceuticals, Inc., Filed With SEC on March 28, 2008)

EX-10.7: FINANCING AGREEMENT (XANODYNE PHARMACEUTICALS INC, Filed With SEC on December 18, 2007)

EX-10.7: FINANCING AGREEMENT (XANODYNE PHARMACEUTICALS INC, Filed With SEC on November 9, 2007)

FINANCING AGREEMENT (XCEL PHARMACEUTICALS INC, Filed With SEC on August 22, 2003)

Financing Agreements in the Pharmaceuticals Industry